UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 21, 2021
Accession Number:
0001193125-21-119305
Submission Type:
POS AM
CIK:
0001175505
Company Name:
FIVE PRIME THERAPEUTICS, INC.
File Number:
333-228206